Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation
(2016)
Journal Article
Zeybel, G. L., Pearson, J. P., Krishnan, A., Bourke, S. J., Doe, S., Anderson, A., Faruqi, S., Morice, A. H., Jones, R., McDonnell, M., Zeybel, M., Dettmar, P. W., Brodlie, M., & Ward, C. (2017). Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation. Journal of Cystic Fibrosis, 16(1), 124-131. https://doi.org/10.1016/j.jcf.2016.07.004
© 2016 The Authors Background Extra-oesophageal reflux (EOR) may lead to microaspiration in patients with cystic fibrosis (CF), a probable cause of deteriorating lung function. Successful clinical trials of ivacaftor highlight opportunities to unders... Read More about Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.